Compounds > ro 5-3335
Page last updated: 2024-08-24

ro 5-3335 and sb 203580

ro 5-3335 has been researched along with sb 203580 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujita, H; Fujiwara, N; Kawakami, H; Nakajima, T; Ueda, Y1

Other Studies

1 other study(ies) available for ro 5-3335 and sb 203580

ArticleYear
Novel piperidinylpyrimidine derivatives as inhibitors of HIV-1 LTR activation.
    Bioorganic & medicinal chemistry, 2008, Nov-15, Volume: 16, Issue:22

    Topics: Animals; Anti-HIV Agents; Cells, Cultured; HIV Long Terminal Repeat; HIV-1; Humans; Inhibitory Concentration 50; Jurkat Cells; Mice; Pyrimidines; Transcriptional Activation; Tumor Necrosis Factor-alpha

2008